Elevated mutant frequencies and increased C

G→T:A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells

Agnes Baross-Francis, Naila Makhani, Robert (Mike) Liskay, Frank R. Jirik

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Mutations in DNA mismatch repair (MMR) genes are associated with increased genomic instability and susceptibility to cancer. Mice rendered deficient in either Mlh1 or Pms2 as a result of gene targeting are prone to tumorigenesis, particularly, lymphomas. In addition, although Mlh1-/- mice also develop small intestinal adenomas and adenocarcinomas, Pms2-/- animals remain free of such tumors. To establish whether this phenotypic dichotomy might be associated with a quantitative and/or qualitative difference in genomic instability in these mice, we determined small intestinal epithelial cell DNA mutant frequency and mutation spectrum using a transgenic λ-phage lacI reporter system. Mutant frequencies obtained from both Mlh1-/- and Pms2-/- mice revealed elevations of 18- and 13-fold, respectively, as compared to their wild-type littermates. Interestingly, we found that C:G→T:A transitions were significantly elevated in Mlh1-/- mice, accounting in large measure for the 1.5-fold lacI mutant frequency increase seen in these animals. We hypothesize that the increased level of C:G→T:A mutations may explain, in part, why Mlh1 -/- mice, but not Pms2-/- mice, develop small intestinal tumors. Furthermore, the difference in the loci mutational spectrum of Mlh1-/- and Pms2-/- mice suggests that other MutL-like heterodimers may play important roles in the repair of G:T mispairs arising within murine small intestinal epithelial cells.

Original languageEnglish (US)
Pages (from-to)619-625
Number of pages7
JournalOncogene
Volume20
Issue number5
DOIs
StatePublished - Feb 1 2001

Fingerprint

Epithelial Cells
Genomic Instability
Neoplasms
Mutation
DNA Mismatch Repair
Gene Targeting
Mutation Rate
Adenoma
Bacteriophages
Lymphoma
Carcinogenesis
Adenocarcinoma
DNA
Genes

Keywords

  • DNA mismatch repair
  • lacI
  • Mlh1
  • Pms2
  • Transgenic

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Elevated mutant frequencies and increased C : G→T:A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells. / Baross-Francis, Agnes; Makhani, Naila; Liskay, Robert (Mike); Jirik, Frank R.

In: Oncogene, Vol. 20, No. 5, 01.02.2001, p. 619-625.

Research output: Contribution to journalArticle

Baross-Francis, Agnes ; Makhani, Naila ; Liskay, Robert (Mike) ; Jirik, Frank R. / Elevated mutant frequencies and increased C : G→T:A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells. In: Oncogene. 2001 ; Vol. 20, No. 5. pp. 619-625.
@article{433945c1a0e84c11a81fe6fd11e3a716,
title = "Elevated mutant frequencies and increased C: G→T:A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells",
abstract = "Mutations in DNA mismatch repair (MMR) genes are associated with increased genomic instability and susceptibility to cancer. Mice rendered deficient in either Mlh1 or Pms2 as a result of gene targeting are prone to tumorigenesis, particularly, lymphomas. In addition, although Mlh1-/- mice also develop small intestinal adenomas and adenocarcinomas, Pms2-/- animals remain free of such tumors. To establish whether this phenotypic dichotomy might be associated with a quantitative and/or qualitative difference in genomic instability in these mice, we determined small intestinal epithelial cell DNA mutant frequency and mutation spectrum using a transgenic λ-phage lacI reporter system. Mutant frequencies obtained from both Mlh1-/- and Pms2-/- mice revealed elevations of 18- and 13-fold, respectively, as compared to their wild-type littermates. Interestingly, we found that C:G→T:A transitions were significantly elevated in Mlh1-/- mice, accounting in large measure for the 1.5-fold lacI mutant frequency increase seen in these animals. We hypothesize that the increased level of C:G→T:A mutations may explain, in part, why Mlh1 -/- mice, but not Pms2-/- mice, develop small intestinal tumors. Furthermore, the difference in the loci mutational spectrum of Mlh1-/- and Pms2-/- mice suggests that other MutL-like heterodimers may play important roles in the repair of G:T mispairs arising within murine small intestinal epithelial cells.",
keywords = "DNA mismatch repair, lacI, Mlh1, Pms2, Transgenic",
author = "Agnes Baross-Francis and Naila Makhani and Liskay, {Robert (Mike)} and Jirik, {Frank R.}",
year = "2001",
month = "2",
day = "1",
doi = "10.1038/sj.onc.1204138",
language = "English (US)",
volume = "20",
pages = "619--625",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Elevated mutant frequencies and increased C

T2 - G→T:A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells

AU - Baross-Francis, Agnes

AU - Makhani, Naila

AU - Liskay, Robert (Mike)

AU - Jirik, Frank R.

PY - 2001/2/1

Y1 - 2001/2/1

N2 - Mutations in DNA mismatch repair (MMR) genes are associated with increased genomic instability and susceptibility to cancer. Mice rendered deficient in either Mlh1 or Pms2 as a result of gene targeting are prone to tumorigenesis, particularly, lymphomas. In addition, although Mlh1-/- mice also develop small intestinal adenomas and adenocarcinomas, Pms2-/- animals remain free of such tumors. To establish whether this phenotypic dichotomy might be associated with a quantitative and/or qualitative difference in genomic instability in these mice, we determined small intestinal epithelial cell DNA mutant frequency and mutation spectrum using a transgenic λ-phage lacI reporter system. Mutant frequencies obtained from both Mlh1-/- and Pms2-/- mice revealed elevations of 18- and 13-fold, respectively, as compared to their wild-type littermates. Interestingly, we found that C:G→T:A transitions were significantly elevated in Mlh1-/- mice, accounting in large measure for the 1.5-fold lacI mutant frequency increase seen in these animals. We hypothesize that the increased level of C:G→T:A mutations may explain, in part, why Mlh1 -/- mice, but not Pms2-/- mice, develop small intestinal tumors. Furthermore, the difference in the loci mutational spectrum of Mlh1-/- and Pms2-/- mice suggests that other MutL-like heterodimers may play important roles in the repair of G:T mispairs arising within murine small intestinal epithelial cells.

AB - Mutations in DNA mismatch repair (MMR) genes are associated with increased genomic instability and susceptibility to cancer. Mice rendered deficient in either Mlh1 or Pms2 as a result of gene targeting are prone to tumorigenesis, particularly, lymphomas. In addition, although Mlh1-/- mice also develop small intestinal adenomas and adenocarcinomas, Pms2-/- animals remain free of such tumors. To establish whether this phenotypic dichotomy might be associated with a quantitative and/or qualitative difference in genomic instability in these mice, we determined small intestinal epithelial cell DNA mutant frequency and mutation spectrum using a transgenic λ-phage lacI reporter system. Mutant frequencies obtained from both Mlh1-/- and Pms2-/- mice revealed elevations of 18- and 13-fold, respectively, as compared to their wild-type littermates. Interestingly, we found that C:G→T:A transitions were significantly elevated in Mlh1-/- mice, accounting in large measure for the 1.5-fold lacI mutant frequency increase seen in these animals. We hypothesize that the increased level of C:G→T:A mutations may explain, in part, why Mlh1 -/- mice, but not Pms2-/- mice, develop small intestinal tumors. Furthermore, the difference in the loci mutational spectrum of Mlh1-/- and Pms2-/- mice suggests that other MutL-like heterodimers may play important roles in the repair of G:T mispairs arising within murine small intestinal epithelial cells.

KW - DNA mismatch repair

KW - lacI

KW - Mlh1

KW - Pms2

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=0035253196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035253196&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204138

DO - 10.1038/sj.onc.1204138

M3 - Article

VL - 20

SP - 619

EP - 625

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 5

ER -